Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (3106)	9/23/2003 8:06:35 AM
From: JoeinIowa	Read Replies (1) \| Respond to of 23958

News for 'LSBC' - (Large Scale Biology Corporation Awarded Biomarker Research Grant) GERMANTOWN, Md., Sep 23, 2003 (BUSINESS WIRE) -- Large Scale Biology Corporation (Nasdaq:LSBC) has been awarded a grant by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for research leading to the discovery of biomarkers for alcohol-related diseases. Discovery of significant protein factors are expected to impact early diagnosis, monitoring and treatment of alcoholic diseases. The work will be conducted at LSBC's Proteomics Division. The study will generate a comprehensive database of changes in protein expression from different areas of the brain as induced by alcohol-related phenomena. LSBC's proprietary ProGEx(TM) protein expression technology will separate, quantify and identify proteins exhibiting significant correlations. The work will include collaboration with the Indiana University Alcohol Research Center, a specialized alcoholism research facility funded by NIAAA. "This proteomics study for NIAAA represents an application of LSBC technology in the vast and promising area of brain research," said Kevin J. Ryan, president and CEO of LSBC. "We are pleased by this opportunity to contribute to the mission of NIAAA and the global health implications of its focus." About Large Scale Biology Corporation Large Scale Biology is an integrated biotechnology company focusing on product development and biomanufacturing of protein and peptide therapeutics and vaccines. Corporate offices and R&D are headquartered in Vacaville, Calif.; the Company's Proteomics Division is located in Germantown, Md.; and the Company's Biomanufacturing Division is located in Owensboro, Ky. For more information about Large Scale Biology Corporation, visit the Company's Web site at www.lsbc.com. Some statements contained in this release constitute forward-looking statements that involve substantial risks and uncertainties. In some cases, you can identify these statements by words such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," or "continue" and variations of these words or comparable words. In addition, any statements which refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. These forward-looking statements involve risks, uncertainties and situations that may cause our actual results, level of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these statements, including the ability of our collaborators and customers to generate demand for our product or products we make for them, any difficulties or delays in obtaining regulatory approval to market products we make, and the requirement of substantial funding for us and our customers to expand commercial activities. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements, which apply only as of the date of this release. For a further list and description of such risks and uncertainties see the reports filed by Large Scale Biology Corporation with the Securities and Exchange Commission, including our reports on Forms 10-K and 10-Q. Except as required by law, we do not undertake to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. LSBC(TM) and ProGEx(TM) are trademarks of Large Scale Biology Corporation. SOURCE: Large Scale Biology Corporation